[go: up one dir, main page]

IS6360A - Medicines for the treatment of hepatitis C - Google Patents

Medicines for the treatment of hepatitis C

Info

Publication number
IS6360A
IS6360A IS6360A IS6360A IS6360A IS 6360 A IS6360 A IS 6360A IS 6360 A IS6360 A IS 6360A IS 6360 A IS6360 A IS 6360A IS 6360 A IS6360 A IS 6360A
Authority
IS
Iceland
Prior art keywords
hepatitis
medicines
treatment
Prior art date
Application number
IS6360A
Other languages
Icelandic (is)
Inventor
Nowicky Wassyl
Original Assignee
Nowicky Wassyl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nowicky Wassyl filed Critical Nowicky Wassyl
Publication of IS6360A publication Critical patent/IS6360A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IS6360A 2000-03-22 2002-04-24 Medicines for the treatment of hepatitis C IS6360A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (en) 2000-03-22 2000-03-22 AGENT FOR TREATING HEPATITIS C
PCT/AT2001/000076 WO2001070203A2 (en) 2000-03-22 2001-03-20 Agent for treating hepatitis c containing ukrain

Publications (1)

Publication Number Publication Date
IS6360A true IS6360A (en) 2002-04-24

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6360A IS6360A (en) 2000-03-22 2002-04-24 Medicines for the treatment of hepatitis C

Country Status (17)

Country Link
JP (1) JP2003527414A (en)
KR (1) KR20020087045A (en)
CN (1) CN1416347A (en)
AT (1) AT408719B (en)
AU (1) AU2001239000A1 (en)
BG (1) BG107088A (en)
BR (1) BR0107211A (en)
CA (1) CA2389173A1 (en)
EA (1) EA200200584A1 (en)
HR (1) HRP20020367A2 (en)
IL (1) IL149314A0 (en)
IS (1) IS6360A (en)
MA (1) MA25509A1 (en)
MX (1) MXPA02004993A (en)
NO (1) NO20022253D0 (en)
PL (1) PL365000A1 (en)
WO (1) WO2001070203A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (en) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Process for reacting alkaloids.
EP1459753A1 (en) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Quaternary chelidonine and alkaloid derivatives, process for their preparation and their use in the manufacture of medicaments
CA2664935A1 (en) * 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c
CN106343303A (en) * 2015-07-13 2017-01-25 张如安 Beverage for killing hepatitis B virus
CN106109538A (en) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 The pharmaceutical composition for the treatment of hepatitis C

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (en) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "METHOD FOR DIAGNOSTICING AND FOR THE THERAPEUTIC TREATMENT OF TUMORS AND / OR INFECTIOUS DISEASES OF DIFFERENT TYPES WITH PREPARATIVE USE OF ALKALOID COMPOUNDS OR THEIR SALTS"
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
PT93772A (en) * 1989-04-17 1991-01-08 Searle & Co PROCESS FOR THE PREPARATION OF COMPOSITIONS FOR THE TREATMENT OF NEOPLASMS, CONTAINING AN ANTI-NEOPLASTIC AGENT, FOR EXAMPLE DOXORUBICIN AND A PROTEIN AGENT TO REDUCE THE SIDE EFFECTS, FOR EXAMPLE CARBETIMER

Also Published As

Publication number Publication date
PL365000A1 (en) 2004-12-27
WO2001070203A2 (en) 2001-09-27
NO20022253L (en) 2002-05-10
KR20020087045A (en) 2002-11-21
JP2003527414A (en) 2003-09-16
MXPA02004993A (en) 2003-10-14
CA2389173A1 (en) 2001-09-27
MA25509A1 (en) 2002-07-01
ATA4812000A (en) 2001-07-15
HRP20020367A2 (en) 2004-02-29
CN1416347A (en) 2003-05-07
NO20022253D0 (en) 2002-05-10
WO2001070203A3 (en) 2002-09-06
EA200200584A1 (en) 2003-06-26
AT408719B (en) 2002-02-25
IL149314A0 (en) 2002-11-10
AU2001239000A1 (en) 2001-10-03
BG107088A (en) 2003-05-30
BR0107211A (en) 2004-01-06

Similar Documents

Publication Publication Date Title
IS5982A (en) Process for the preparation of 5-cyanothalide
DK1093370T3 (en) Pharmaceutical preparation for the treatment of diabetes
DE60142473D1 (en) INTRAKORPORAL MEDICAMENTS FOR THE PHOTODYNAMIC TREATMENT OF ILLNESSES
IS6286A (en) Ischemic treatment compounds
DE60121953D1 (en) METHOD OF MANUFACTURING MEDICINE PREPARATIONS
IS2711B3 (en) Process for the preparation of amine-platinum complexes
EP1296698A4 (en) THERAPEUTIC COMPOUNDS
DK1259512T3 (en) Pteridine compounds for the treatment of psoreasis
NL1015859A1 (en) Pharmaceutical preparations.
DK1345910T3 (en) Quinazoline derivatives, drugs containing the compounds, their use and process for their preparation
DK1147083T3 (en) Arylpiperazinyl-cyclohexylindole derivatives for the treatment of depression
NO20030627L (en) Hydrogel-driven drug dosage form
NO20014490D0 (en) Medical mixtures
IS2261B (en) Process for the preparation of 5-cyanothalide
ATE384522T1 (en) MEDICATIONS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES
ATE265852T1 (en) FLAVORED LIQUID MEDICINAL PREPARATIONS
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
MXPA03001425A (en) PHARMACEUTICAL COMPOUNDS.
IS7137A (en) Combination treatment for the treatment of cancer
IS7929A (en) Oral solid oral medicine
NO20023482D0 (en) Procedure for the treatment of substance abuse
PL354028A1 (en) Pharmaceutical solutions of levosimendan Pharmaceutical solutions of levosimendan
NO20013958L (en) Medication for the treatment of high blood pressure
IS2296B (en) Process for the preparation of protected 4-aminomethyl-pyrrolidin-3-one.
BR0000687B1 (en) Disposable intimate part.